BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 31338732)

  • 1. Nicotinic treatment of post-chemotherapy subjective cognitive impairment: a pilot study.
    Vega JN; Albert KM; Mayer IA; Taylor WD; Newhouse PA
    J Cancer Surviv; 2019 Oct; 13(5):673-686. PubMed ID: 31338732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subjective cognition and mood in persistent chemotherapy-related cognitive impairment.
    Vega JN; Albert KM; Mayer IA; Taylor WD; Newhouse PA
    J Cancer Surviv; 2022 Jun; 16(3):614-623. PubMed ID: 33973154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-reported chemotherapy-related cognitive impairment compared with cognitive complaints following menopause.
    Vega JN; Dumas J; Newhouse PA
    Psychooncology; 2018 Sep; 27(9):2198-2205. PubMed ID: 29904964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transdermal Nicotine for the Treatment of Mood and Cognitive Symptoms in Nonsmokers With Late-Life Depression.
    Gandelman JA; Kang H; Antal A; Albert K; Boyd BD; Conley AC; Newhouse P; Taylor WD
    J Clin Psychiatry; 2018 Aug; 79(5):. PubMed ID: 30192444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study of donepezil in female breast cancer survivors with self-reported cognitive dysfunction 1 to 5 years following adjuvant chemotherapy.
    Lawrence JA; Griffin L; Balcueva EP; Groteluschen DL; Samuel TA; Lesser GJ; Naughton MJ; Case LD; Shaw EG; Rapp SR
    J Cancer Surviv; 2016 Feb; 10(1):176-84. PubMed ID: 26130292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotine treatment of mild cognitive impairment: a 6-month double-blind pilot clinical trial.
    Newhouse P; Kellar K; Aisen P; White H; Wesnes K; Coderre E; Pfaff A; Wilkins H; Howard D; Levin ED
    Neurology; 2012 Jan; 78(2):91-101. PubMed ID: 22232050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of chemotherapy on cognitive function: a multicentre prospective cohort study in testicular cancer.
    Whitford HS; Kalinowski P; Schembri A; Grimison P; Stockler M; Martin A; Toner GC; Davis ID; Maruff P; Olver IN;
    Support Care Cancer; 2020 Jul; 28(7):3081-3091. PubMed ID: 31642990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perceived cognitive impairment in people with colorectal cancer who do and do not receive chemotherapy.
    Dhillon HM; Tannock IF; Pond GR; Renton C; Rourke SB; Vardy JL
    J Cancer Surviv; 2018 Apr; 12(2):178-185. PubMed ID: 29080061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of quality of life among adults with self-reported cancer related cognitive impairment.
    Maeir T; Nahum M; Makranz C; Tsabari S; Peretz T; Gilboa Y
    Disabil Rehabil; 2023 Mar; 45(6):1056-1062. PubMed ID: 35297702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive rehabilitation program to improve cognition of cancer patients treated with chemotherapy: A 3-arm randomized trial.
    Dos Santos M; Hardy-Léger I; Rigal O; Licaj I; Dauchy S; Levy C; Noal S; Segura C; Delcambre C; Allouache D; Parzy A; Barriere J; Petit T; Lange M; Capel A; Clarisse B; Grellard JM; Lefel J; Joly F
    Cancer; 2020 Dec; 126(24):5328-5336. PubMed ID: 32996583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlates of cognitive impairment in adult cancer survivors who have received chemotherapy and report cognitive problems.
    Gutenkunst SL; Vardy JL; Dhillon HM; Bell ML
    Support Care Cancer; 2021 Mar; 29(3):1377-1386. PubMed ID: 32666213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subjective and objective cognitive functioning among patients with breast cancer: effects of chemotherapy and mood symptoms.
    Hsu YH; Chen VC; Hsieh CC; Weng YP; Hsu YT; Hsiao HP; Wang WK; Chen HM; Weng JC; Wu SI; Gossop M
    Breast Cancer; 2021 Jan; 28(1):236-245. PubMed ID: 33030667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rivastigmine Transdermal Patch Treatment for Moderate to Severe Cognitive Impairment in Veterans with Traumatic Brain Injury (RiVET Study): A Randomized Clinical Trial.
    Brawman-Mintzer O; Tang XC; Bizien M; Harvey PD; Horner MD; Arciniegas DB; Raskind M; Johnson-Greene L; Martineau RJ; Hamner M; Rodriguez-Suarez M; Jorge RE; McGarity S; Wortzel HS; Wei Y; Sindowski T; Mintzer J; Kindy AZ; Donovan K; Reda D
    J Neurotrauma; 2021 Jul; 38(14):1943-1952. PubMed ID: 33514274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of aerobic exercise on cancer-associated cognitive impairment: A proof-of-concept RCT.
    Campbell KL; Kam JWY; Neil-Sztramko SE; Liu Ambrose T; Handy TC; Lim HJ; Hayden S; Hsu L; Kirkham AA; Gotay CC; McKenzie DC; Boyd LA
    Psychooncology; 2018 Jan; 27(1):53-60. PubMed ID: 28075038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subjective cognitive impairment and brain structural networks in Chinese gynaecological cancer survivors compared with age-matched controls: a cross-sectional study.
    Zeng Y; Cheng ASK; Song T; Sheng X; Zhang Y; Liu X; Chan CCH
    BMC Cancer; 2017 Nov; 17(1):796. PubMed ID: 29179739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pupillary response: cognitive effort for breast cancer survivors.
    Myers JS; Kahya M; Mitchell M; Dai J; He J; Moon S; Hamilton K; Valla M; O'Dea A; Klemp J; Kurylo M; Akinwuntan A; Devos H
    Support Care Cancer; 2019 Mar; 27(3):1121-1128. PubMed ID: 30097791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct and heterogeneous trajectories of self-perceived cognitive impairment among Asian breast cancer survivors.
    Ng T; Dorajoo SR; Cheung YT; Lam YC; Yeo HL; Shwe M; Gan YX; Foo KM; Loh WK; Koo SL; Jain A; Lee GE; Dent R; Yap YS; Ng R; Chan A
    Psychooncology; 2018 Apr; 27(4):1185-1192. PubMed ID: 29315963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized trial of videoconference-delivered cognitive behavioral therapy for survivors of breast cancer with self-reported cognitive dysfunction.
    Ferguson RJ; Sigmon ST; Pritchard AJ; LaBrie SL; Goetze RE; Fink CM; Garrett AM
    Cancer; 2016 Jun; 122(11):1782-91. PubMed ID: 27135464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive problems of breast cancer survivors on proton pump inhibitors.
    Madison AA; Woody A; Bailey B; Lustberg MB; Ramaswamy B; Wesolowski R; Williams N; Reinbolt R; VanDeusen JB; Sardesai S; Malarkey WB; Kiecolt-Glaser JK
    J Cancer Surviv; 2020 Apr; 14(2):226-234. PubMed ID: 31933149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of chemotherapy on subjective cognitive function in younger early-stage breast cancer survivors treated with chemotherapy compared to older patients.
    Gregorowitsch ML; Ghedri A; Young-Afat DA; Bijlsma R; Baas IO; van Schaik-van de Mheen C; Agterof MJ; Göker E; Ten Bokkel Huinink D; van den Bongard HJGD; Verkooijen HM;
    Breast Cancer Res Treat; 2019 Jun; 175(2):429-441. PubMed ID: 30746636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.